Sa A Wang
Overview
Explore the profile of Sa A Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
320
Citations
5111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DiNardo C, Jen W, Takahashi K, Kadia T, Loghavi S, Daver N, et al.
Leukemia
. 2025 Feb;
PMID: 40000842
Intensive chemotherapy remains the standard for newly diagnosed (ND) acute myeloid leukemia (AML); however, relapse risk remains high. Additionally, most patients with relapsed/refractory (RR) AML have poor outcomes. We report...
2.
Hamdan H, Liu Y, Wang S, Bledsoe J, Chisholm K, Siddon A, et al.
EJHaem
. 2025 Jan;
6(1):e1052.
PMID: 39866946
Background: Acute myeloid leukemia (AML) with RAM immunophenotype is a newly recognized high-risk AML immunophenotypic subcategory characterized by blasts with bright expression of CD56 and weak to absent expression of...
3.
Kim D, Kim D, Medeiros L, Xu J, Tang G, Qiu L, et al.
Mod Pathol
. 2025 Jan;
38(5):100710.
PMID: 39805522
Classification of cases of diffuse large B-cell lymphoma (DLBCL)/high-grade B-cell lymphoma (HGBL) with MYC and BCL6 rearrangements, referred to here as BCL6 double-hit lymphoma (DHL), is controversial. We assessed 60...
4.
Sameeta F, Wang W, Jelloul F, Nwogbo O, Thakral B, Xu J, et al.
Arch Pathol Lab Med
. 2024 Dec;
PMID: 39711284
Context.—: Blasts in myelodysplastic syndromes (MDSs) typically have a primitive myeloid immunophenotype (CD34+CD117+CD13+CD33+HLA-DR+). On rare occasions, blasts were found to be CD34 negative or minimally expressed in a presumptive MDS....
5.
Fang H, Wang S, Medeiros L, Wang W
Hum Pathol
. 2024 Dec;
156:105711.
PMID: 39709144
Flow cytometry immunophenotyping (FCI) is an important and indispensable tool in the diagnosis of mature B-cell lymphomas/leukemias, particularly for small fine needle aspiration and needle core biopsy specimens which are...
6.
Jen W, Jen W, Sasaki K, Ravandi F, Kadia T, Wang S, et al.
Blood Adv
. 2024 Dec;
9(4):783-792.
PMID: 39631072
The prognostic impact of measurable residual disease (MRD) in acute myeloid leukemia (AML) is unequivocal; however, the optimal time point for achieving undetectable MRD is unclear. We retrospectively studied patients...
7.
Kirtek T, Chen W, Harris J, Bagg A, Foucar K, Tam W, et al.
Am J Hematol
. 2024 Nov;
100(2):300-304.
PMID: 39578955
No abstract available.
8.
Hamilton M, Greene L, Madigan L, Wang S, Arana Yi C, Kuykendall A, et al.
Front Allergy
. 2024 Nov;
5:1401187.
PMID: 39493747
Systemic mastocytosis (SM) is a rare hematologic condition characterized by the proliferation and accumulation in tissue of clonal mast cells in multiple organ systems. The release of mast cell mediators...
9.
Komrokji R, Lanino L, Ball S, Bewersdorf J, Marchetti M, Maggioni G, et al.
Lancet Haematol
. 2024 Oct;
11(11):e862-e872.
PMID: 39393368
The WHO and International Consensus Classification 2022 classifications of myelodysplastic syndromes enhance diagnostic precision and refine decision-making processes in these diseases. However, some discrepancies still exist and potentially cause inconsistency...
10.
Dimopoulos Y, Wang W, Wang S, Loghavi S, DiNardo C, Gerstein Y, et al.
Am J Hematol
. 2024 Oct;
99(12):2416-2419.
PMID: 39392132
No abstract available.